MJ Biz Daily
Innovative trial will use psilocybin to target relapse in opioid addiction
Filament Health Announces Issuance Of Common Shares To Negev Capital Investments Limited Pursuant To Advisory Agreement
Filament Health Announces Second Quarter 2024 Financial Results And Operational Highlights
